According to the latest data from the Hong Kong Stock Exchange, on April 17, JPMorgan reduced its holding in Pharmaron (03759) by 605,052 shares. The transaction was executed at a price of HK$21.3947 per share, amounting to a total value of approximately HK$12.9449 million. Following this reduction, JPMorgan's updated shareholding stands at around 21.0476 million shares, representing a stake of 5.84%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments